Chubby (@kimmonismus)

Revolution Medicines의 실험적 췌장암 치료제 daraxonrasib이 후기 임상 3상에서 큰 성과를 냈다는 소식입니다. 생존 기간을 크게 늘리고 사망 위험을 낮춘 결과로, AI와 직접 관련은 없지만 바이오 분야의 중요한 혁신 소식입니다.

https://x.com/kimmonismus/status/2043799856037204372

#clinicaltrial #biotech #cancer #drug

Chubby♨️ (@kimmonismus) on X

Your daily dose of good news: Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial Experimental drug daraxonrasib delivered stunning Phase 3 results, nearly doubling survival (13.2 vs. 6.7 months) and cutting the risk of death

X (formerly Twitter)
Clinical trial shows gene editing works for β-Thalassaemia, too https://arstechni.ca/Q84k -Thalassaemia #clinicaltrial #geneediting #Science #Health #CRISPR
Clinical trial shows gene editing works for β-Thalassaemia, too

Improved gene editing process reactivates the fetal version of a hemoglobin gene.

Ars Technica
India has launched the world’s first clinical trial to study Ayurveda alongside standard TB treatment. The trial will assess safety, recovery, and quality of life in 1,250 patients. https://english.mathrubhumi.com/lifestyle/health/india-clinical-trial-ayurveda-tb-treatment-jj35u5kw?utm_source=dlvr.it&utm_medium=mastodon #Ayurveda #Tuberculosis #TBResearch #IndiaHealth #ClinicalTrial

Oral PCSK9 Inhibitor Enlicitide Reduces LDL Cholesterol by Approximately 60% in Phase 3 Trial

📰 Original title: New pill cuts “bad” cholesterol by 60% in major trial

🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️

View full AI summary: https://killbait.com/en/oral-pcsk9-inhibitor-enlicitide-reduces-ldl-cholesterol-by-approximately-60-in-phase-3-trial/?redirpost=cee93522-b80d-43fc-aa95-396287d3e6e5

#health #cholesterol #pcsk9inhibitor #clinicaltrial

Oral PCSK9 Inhibitor Enlicitide Reduces LDL Cholesterol by Approximately 60% in Phase 3 Trial

A phase 3 clinical trial published in The New England Journal of Medicine demonstrated that enlicitide, an experimental oral PCSK9 inhibitor developed by Merck, significantly lowered low-density…

KillBait Archive
Edmonton clinical trial offers hope to people suffering ‘most severe pains known to mankind’
A new U of A clinical trial is testing ultra-early Gamma Knife surgery to stop trigeminal neuralgia before permanent brain changes and years of devastating pain.
#Health #GammaKnife #GammaKnifeSurgery #HealthMattersEdmonton
https://globalnews.ca/news/11733003/edmonton-trial-gamma-knife-severe-condition/
Edmonton clinical trial offers hope to people suffering ‘most severe pains known to mankind’
A new U of A clinical trial is testing ultra-early Gamma Knife surgery to stop trigeminal neuralgia before permanent brain changes and years of devastating pain.
#Health #GammaKnife #GammaKnifeSurgery #HealthMattersEdmonton
https://globalnews.ca/news/11733003/edmonton-trial-gamma-knife-severe-condition/
Edmonton clinical trial offers hope to people suffering ‘most severe pains known to mankind’
A new U of A clinical trial is testing ultra-early Gamma Knife surgery to stop trigeminal neuralgia before permanent brain changes and years of devastating pain.
#Health #GammaKnife #GammaKnifeSurgery #HealthMattersEdmonton
https://globalnews.ca/news/11733003/edmonton-trial-gamma-knife-severe-condition/
Edmonton clinical trial offers hope to people suffering ‘most severe pains known to mankind’
A new U of A clinical trial is testing ultra-early Gamma Knife surgery to stop trigeminal neuralgia before permanent brain changes and years of devastating pain.
#Health #GammaKnife #GammaKnifeSurgery #HealthMattersEdmonton
https://globalnews.ca/news/11733003/edmonton-trial-gamma-knife-severe-condition/

Here's the third (and last!) entry in a series of blog posts on the #cdisc Dataset-JSON standard. This entry goes over the REST API component and potential issues with it.

Pushing for the future of #clinicaltrial #data (and related to the #pharmaverse and #rstats folks in #biomedicalresearch) and better workflows for running those trials.

https://brianrepko.github.io/blog/posts/2026-03-11-datasetjson-part3/

Dataset-JSON – Learning, Thinking, and Coding

Part 3 - the REST API (and issues)